Read More Pharma Industry News Can evenamide become the first real breakthrough for treatment-resistant schizophrenia? Newron Pharmaceuticals reveals evenamide data at WCBP 2025, showcasing new hope for treatment-resistant schizophrenia through glutamate modulation. byPallavi MadhirajuSeptember 5, 2025